FIELD: medicine.
SUBSTANCE: invention aims at treating the patients with incipient signs of epiretinal membrane (ERM). A laser device is used to coagulate an epiretinal membrane area at contact thereof with a retina. A laser light wavelength is 577 nm; a power is 100-200 W; an exposure length is 20-25 ns; a pulse rate is 10-15%; a spot diameter is 100 mcm; the coagulate number is 50-150.
EFFECT: method enables stabilising the process of ERM growth that leads to improving visual functions and reduces a risk of undesired effects.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINED LASER TREATMENT OF INITIAL STAGE OF EPIRETINAL FIBROSIS | 2016 |
|
RU2634684C1 |
| METHOD FOR TREATMENT OF MACULAR RETINAL FOLDING | 2021 |
|
RU2776768C1 |
| METHOD OF LASER TREATMENT OF TRANSUDATIVE RETINOPATHY AFTER SURGICAL ABLATION OF EPIRETINAL MEMBRANE | 2012 |
|
RU2481088C1 |
| METHOD FOR CYSTIC MACULAR EDEMA LASER TREATMENT | 2016 |
|
RU2622378C1 |
| METHOD FOR CENTRAL SEROUS CHORIORETINOPATHY THERAPY | 2016 |
|
RU2629804C1 |
| METHOD OF TREATMENT OF MACULAR FOR AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2647142C1 |
| METHOD OF CENTRAL SEROUS CHORIORETINOPATHY TREATMENT | 2022 |
|
RU2797276C1 |
| METHOD OF COMBINED LASER TREATMENT OF DRUSENOID SEPARATION OF RETINAL PIGMENT EPITHELIUM | 2019 |
|
RU2727035C1 |
| METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
| METHOD OF DIFFERENTIATED APPROACH TO SURGICAL TREATMENT OF CHRONIC FORM OF CENTRAL SEROUS CHORIORETINOPATHY | 2024 |
|
RU2823160C1 |
